BACKGROUND
Although heart failure (HF) patients are known to experience repeated hospitalizations, most studies evaluated only time to first event. N-Terminal Btype natriuretic peptide (NT-proBNP)-guided therapy has not convincingly been shown to improve HF-specific outcomes, and effects on recurrent all-cause hospitalization are uncertain. Therefore, we investigated the effect of NT-proBNP-guided therapy on recurrent events in HF with the use of a timebetween-events approach in a hypothesis-generating analysis.
METHODS AND RESULTS

The Trial of Intensified Versus Standard Medical Therapy in Elderly Patients
With Congestive Heart Failure (TIME-CHF) randomized 499 HF patients, aged for all-cause hospitalization and HF hospitalization events, respectively).
CONCLUSION
